ClinicalTrials.gg
Not yet recruitingNCT07507045E-OHPUpdated Oct 21, 2026

Education-Based Oral Health Promotion Intervention During Pregnancy: Implementation Protocol in Bangladesh

An interventional study of Integrated Oral Health Promotion Package (IOHPP) in Pregnancy, Periodontal Diseases and Oral Hygiene, Oral Health, sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Not yet recruiting at 1 site in Bangladesh. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Not applicable, Interventional, and Prevention

Updated Oct 21, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
688
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

In Bangladesh, over 95% of pregnant women suffer from gum disease (gingivitis or periodontitis), yet oral health is rarely included in standard pregnancy check-ups. This study tests a new "Integrated Oral Health Promotion Package" to see if teaching oral hygiene during routine prenatal visits can improve the health of mothers. Pregnant women (ages 18-45) will be divided into two groups. The intervention group will receive two face-to-face education sessions with a dental assistant, learn a specific tooth-brushing technique, and receive weekly SMS text reminders to brush their teeth. The control group will receive the standard pregnancy care currently offered in Bangladesh. Researchers will track the participants for 12 weeks to see if the education and reminders lead to better brushing habits (twice-daily) and cleaner teeth and gums compared to the standard care group.

Read the detailed description

Study Design and Ethical Oversight This cluster-randomized, hybrid effectiveness-implementation trial (Protocol Version 1.1, March 2026) utilizes the PRECEDE-PROCEED framework to address maternal oral health in Bangladesh. The study is conducted in eight Upazila Health Complexes (UHCs) across eight administrative divisions. This protocol and all recruitment materials have been approved by the IRB of Bangladesh Medical University. Any future amendments to the protocol or study sites will be submitted for board approval before implementation. To prevent treatment contamination, staff at intervention sites will not rotate to control sites, and clinical examiners remain blinded to the 1:1 cluster allocation throughout the 12-week follow-up.

Participant Enrollment and Power A total of 688 pregnant women (86 per cluster) with a gestational age ≤24 weeks will be recruited. The sample size provides 80% power at a 5% significance level to detect a 20% improvement in the primary outcome, assuming a 1.5 design effect (ICC = 0.05) and a 20% attrition rate.

Statistical Analysis Plan (SAP) and Assumption Verification Analysis follows the Intention-to-Treat (ITT) principle using Mixed-Effects Linear Regression for clinical scores (OHI-S) and Mixed-Effects Logistic Regression for binary behavioral outcomes. The UHC is included as a random effect to account for clustering.

  • Verification of Assumptions: To meet PRS requirements for statistical transparency, the normality of continuous outcomes will be verified using Shapiro-Wilk tests and Q-Q plots. If assumptions are violated, non-parametric methods or log transformations will be employed.
  • Multiple Testing: To account for testing multiple variables (OHI-S, Knowledge Score, and Behavior), a Bonferroni correction will be applied to the p-values.
  • Missing Data: If missingness exceeds 5%, Multiple Imputation (m=20) will be used to handle incomplete data.

Outcome Measures The primary clinical endpoint is the Oral Hygiene Index-Simplified (OHI-S), measuring debris and calculus on six tooth surfaces (score 0-6). Secondary endpoints include a 10-item validated Knowledge Score and self-reported behavioral changes in twice-daily brushing frequency from baseline to 12 weeks.

02

Conditions studied

  • Pregnancy
  • Periodontal Diseases
  • Oral Hygiene, Oral Health

Browse trials for

Keywords

  • Maternal oral health
  • Pregnancy
  • Antenatal care
  • Cluster randomized trial
03

In context

Periodontal Diseases

867 studies on the registry are indexed under Periodontal Diseases; 189 are open to participants now.

This study's planned enrollment of 688 is above the median of 45 across 557 interventional studies indexed under Periodontal Diseases.

Browse Periodontal Diseases studies →

Lead sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh is the lead sponsor of 128 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women attending ANC services at participating UHCs
  • Gestational age ≤24 weeks at enrolment to allow follow-up
  • Age 18 years or older
  • Willing and able to provide

Exclusion criteria

Exclusion Criteria:

  • Presence of severe medical or obstetric complications requiring immediate referral
  • Current participation in another behavioural or oral health intervention study
  • Conditions preventing participation in oral examination procedures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
688 participants (estimated)

Study arms

  • Experimental
    Education-Based Intervention

    Participants at the four intervention Upazila Health Complexes (UHCs) will receive routine antenatal care (ANC) plus a structured oral health package. This includes two face-to-face education sessions, tooth-brushing and flossing demonstrations, weekly SMS reminders, and pictorial educational materials.

    Behavioral: Integrated Oral Health Promotion Package (IOHPP)

  • No intervention
    Usual Care

    Participants at the four control Upazila Health Complexes (UHCs) will receive the standard National Antenatal Care (ANC) services currently provided by the government of Bangladesh without the additional oral health education package.

Interventions

  • BehavioralIntegrated Oral Health Promotion Package (IOHPP)

    The Integrated Oral Health Promotion Package (IOHPP) is an education-based intervention embedded within routine Antenatal Care (ANC). It consists of 1) Two 20-30 minute face-to-face education sessions on maternal/child oral health; 2) Practical demonstrations of modified Bass brushing and flossing techniques; 3) Weekly SMS reminders to reinforce twice-daily brushing and healthy dietary habits; and 4) Distribution of pictorial leaflets and guidelines. ANC providers are trained to provide basic oral health counseling and facilitate referrals to dental services. The model uses the PRECEDE-PROCEED framework to address social and behavioral determinants of health in a low-resource setting.

06

What researchers measure

Primary outcomes

  1. Change in Oral Hygiene Index-Simplified (OHI-S) score

    The OHI-S assesses oral hygiene through two components: Debris Index (DI-S) and Calculus Index (CI-S). Six tooth surfaces are examined. The total score ranges from 0 to 6. A score of 0.0-1.2 is Good; 1.3-3.0 is Fair; 3.1-6.0 is Poor

    Time frame: Baseline and 12 weeks.

Secondary outcomes

  1. Change in oral health knowledge scores

    Measured using a structured composite scale assessing knowledge of maternal oral health, hygiene practices, and disease prevention. The scale ranges from 0 to \[Insert your Max Score\], where higher scores indicate better knowledge.

    Time frame: Baseline and 12 weeks.

Other outcomes

  1. Proportion of women brushing twice daily

    Calculated as the percentage of participants who self-report brushing their teeth at least twice per day over the previous 7 days using an interviewer-administered questionnaire.

    Time frame: 12 weeks.

07

Study locations

1 site
08

References and documents

Publications

  • 16. Roslan D, Ruzlin A, Abdullah N, Azhar Z, Azzani M, Chen X, et al. Application of the PRECEDE-PROCEED model: A glimpse into student-led community health program in Malaysia. Eur J Sustain Dev. 2025;14:335. 10.14207/ejsd.2025.v14n4p335
  • Sachelarie L, Iman AEH, Romina MV, Huniadi A, Hurjui LL. Impact of Hormones and Lifestyle on Oral Health During Pregnancy: A Prospective Observational Regression-Based Study. Medicina (Kaunas). 2024 Oct 30;60(11):1773. doi: 10.3390/medicina60111773. PubMed 39596958 ↗
  • 1. Wang S, Jiang J, Li J, et al. The global, regional, and national burden of oral disorders in 204 countries and territories, 1990-2021, and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Regenesis Repair Rehabil. 2025;1(3):56-63 https://doi.org/10.1016/j.rerere.2025.07.001

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — The IPD will be shared after completion of the study through the Zotero data repository

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: 1st may to 31st August 2026

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2027; primary completion for Nov 2027, 5 months later.

Of 312 non-industry interventional studies with no phase under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 27. This study's planned 5 months is below that.

Counting every sponsor, half of 331 studies reached it within 13 months; a quarter within 8 and three quarters within 26.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: start May 2026 → Jun 2027, primary completion Aug 2026 → Nov 2027 and completion Nov 2026 → Jan 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2026
First posted
Apr 2, 2026
StartEst.
Jun 1, 2027was May 2026
Primary completionEst.
Nov 1, 2027was Aug 2026
CompletionEst.
Jan 1, 2028was Nov 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
May 1, 2026→Jun 1, 2027
Oct 21, 2026
Primary completion
Aug 1, 2026→Nov 1, 2027
Oct 21, 2026
Study completion
Nov 1, 2026→Jan 1, 2028
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Start date May 1, 2026→Jun 1, 2027
    Primary completion Aug 1, 2026→Nov 1, 2027
    Study completion Nov 1, 2026→Jan 1, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07507045
Responsible party
Md Atiqul Haque (Professor, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh) — Principal investigator
First posted
Apr 2, 2026
Start date
Jun 1, 2027 (estimated)
Primary completion
Nov 1, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Oct 21, 2026

Study contacts

Nabhira Aftabi Binte Islam, BDS,MPH
Contact
nabhira22@bsmmu.edu.bd
+8801717481594
Md. Atiqul Haque Prof., PhD
Contact
+8801711428141

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion